Vitreous Tamponades to Witness High Demand due to Increasing Incidence of Diabetic Retinopathy, reports TMR The competitive landscape of the global vitreous tamponades market is highly fragmented due to the presence of numerous local and global players, states Transparency Market Research (TMR). Some of the top players operating in the global vitreous tamponades market are Carl Zeiss Meditec AG, Alcon Inc., Fluron GmbH, Valeant Pharmaceuticals International Inc., and Dutch Ophthalmic Research Center B.V. “Expansion of distribution networks and distributor subsidiaries is the strategy top companies in this market are adopting to augment sales,” points out a TMR analyst. For example, Alchimia Srl’s sales in the U.S. and Latin America are handled by Oftalmedia LLC, whereas its sales in other regions are handled by its Italy-based subsidiary BBS Srl.
The introduction of new products and new technologies is another key growth model that leading players in this market are exploring. Strategic mergers and acquisitions for the expansion of distributor base are on the growth plans of leading companies in the global vitreous tamponades market, adds TMR. Declining Rate of Complications due to Diabetes in U.S. Challenges Market Growth The major factor driving the global vitreous tamponades market is the increasing incidence of retinal detachment, macular pucker, and other ophthalmic conditions. Vitreous tamponades are used for the treatment of several vitreoretinal disorders such as retinal detachment, age-related macular degeneration, diabetic retinopathy, and vitreous hemorrhage. For instance, as per the International Diabetes Federation, almost 300 million individuals were affected with diabetes worldwide in 2010 and this number is expected to reach 438 million by 2030. A rising geriatric population that is susceptible to retinal disorders is also favoring the growth of the vitreous tamponades market. Read Full Report: http://www.transparencymarketresearch.com/vitreous-tamponadesmarket.html “The commoditization of the vitreous tamponades market in Asia Pacific, Europe, and Rest of the World is challenging the growth of this market”, says a TMR analyst. Increasing demand for tamponades that are effective in the long-term and the price war that has spurred between local manufacturers and global vendors is adversely affecting industry revenue.